Peng Zeng
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Plant Science
- Pharmacology
- Topics
- Glaucoma and retinal disorders (14 papers)Retinal Diseases and Treatments (11 papers)Ophthalmology and Eye Disorders (9 papers)
- Partner nations
- ChinaItalyNew Zealand
In The Last Decade
Peng Zeng
57 papers receiving 715 citations
Peers
Comparison fields: 5 of 116
- Ophthalmology 236
- Radiology, Nuclear Medicine and Imaging 229
- Molecular Biology 169
- Plant Science 66
- Pharmacology 58
Countries citing papers authored by Peng Zeng
This map shows the geographic impact of Peng Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zeng more than expected).
Fields of papers citing papers by Peng Zeng
This network shows the impact of papers produced by Peng Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zeng. The network helps show where Peng Zeng may publish in the future.
Co-authorship network of co-authors of Peng Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zeng. A scholar is included among the top collaborators of Peng Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zeng. Peng Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 9 | |
| 11 | 11 | |
| 12 | 2 | |
| 13 | 21 | |
| 14 | 25 | |
| 15 | 42 | |
| 16 | 24 | |
| 17 | 4 | |
| 18 | 23 | |
| 19 | Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice. | 26 |
| 20 | 3 |
About Peng Zeng
Peng Zeng is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 60 papers that have together received 729 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (14 papers), Retinal Diseases and Treatments (11 papers) and Ophthalmology and Eye Disorders (9 papers). The work is most often cited by research in Ophthalmology (236 citations), Radiology, Nuclear Medicine and Imaging (229 citations) and Aquatic Science (43 citations). Peng Zeng has collaborated with scholars based in China, Italy and New Zealand. Frequent co-authors include Zijing Li, Yuqing Lan, Yichi Zhang, Jianhui Xiao, Mingming Liu, Liangen Shi, Xiaotong Li, Hu Chen, Tianji Chen and Xin Wen. Their work appears in journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.